JPWO2021070934A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021070934A5 JPWO2021070934A5 JP2021551720A JP2021551720A JPWO2021070934A5 JP WO2021070934 A5 JPWO2021070934 A5 JP WO2021070934A5 JP 2021551720 A JP2021551720 A JP 2021551720A JP 2021551720 A JP2021551720 A JP 2021551720A JP WO2021070934 A5 JPWO2021070934 A5 JP WO2021070934A5
- Authority
- JP
- Japan
- Prior art keywords
- molecule
- binds
- subject
- component
- bc2lcn
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 21
- 239000012472 biological sample Substances 0.000 claims 10
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 9
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 9
- 201000002528 pancreatic cancer Diseases 0.000 claims 9
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 9
- 238000003556 assay Methods 0.000 claims 6
- 206010028980 Neoplasm Diseases 0.000 claims 5
- 201000011510 cancer Diseases 0.000 claims 5
- 102000004856 Lectins Human genes 0.000 claims 4
- 108090001090 Lectins Proteins 0.000 claims 4
- 239000002523 lectin Substances 0.000 claims 4
- 102000003886 Glycoproteins Human genes 0.000 claims 2
- 108090000288 Glycoproteins Proteins 0.000 claims 2
- 238000001042 affinity chromatography Methods 0.000 claims 2
- 238000001962 electrophoresis Methods 0.000 claims 2
- 238000004949 mass spectrometry Methods 0.000 claims 2
- 238000003317 immunochromatography Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019187197 | 2019-10-11 | ||
| JP2019187197 | 2019-10-11 | ||
| PCT/JP2020/038300 WO2021070934A1 (ja) | 2019-10-11 | 2020-10-09 | がんの検査方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2021070934A1 JPWO2021070934A1 (cg-RX-API-DMAC7.html) | 2021-04-15 |
| JPWO2021070934A5 true JPWO2021070934A5 (cg-RX-API-DMAC7.html) | 2023-10-13 |
| JP7656829B2 JP7656829B2 (ja) | 2025-04-04 |
Family
ID=75438180
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021551720A Active JP7656829B2 (ja) | 2019-10-11 | 2020-10-09 | がんの検査方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12618842B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4043881A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7656829B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102896955B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN114556101B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021070934A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2022182394A (ja) * | 2021-05-28 | 2022-12-08 | 独立行政法人国立病院機構 | 抗原固相化デバイス |
| WO2025187809A1 (ja) * | 2024-03-08 | 2025-09-12 | 富士フイルム株式会社 | 検出対象物質を免疫学的に検出する方法、非特異反応を抑制する方法、フコース含有組成物、および試薬キット |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6596476B1 (en) * | 1989-12-22 | 2003-07-22 | Abbott Laboratories | Hepatitis C assay |
| JP5977743B2 (ja) | 2011-06-15 | 2016-08-24 | 三洋化成工業株式会社 | 磁性シリカ粒子を用いた測定方法及び該測定方法用試薬 |
| WO2013172105A1 (ja) * | 2012-05-18 | 2013-11-21 | 日東紡績株式会社 | 膵臓癌を検出するためのマーカー |
| WO2014126146A1 (ja) | 2013-02-14 | 2014-08-21 | 独立行政法人産業技術総合研究所 | 未分化細胞除去方法 |
| US20180250360A1 (en) | 2015-10-05 | 2018-09-06 | National Institute Of Advanced Industrial Science And Technology | Method for detecting cancer cells, reagent for introducing substance into cancer cells, and composition for treating cancer |
| US11078254B2 (en) | 2017-04-11 | 2021-08-03 | National Institute Of Advanced Industrial Science And Technology | Method for immobilizing lectin |
| JP7386647B2 (ja) | 2018-08-13 | 2023-11-27 | 東ソー株式会社 | 糖鎖への親和性が向上したフコース結合性タンパク質、およびその製造方法 |
-
2020
- 2020-10-09 EP EP20873535.7A patent/EP4043881A4/en active Pending
- 2020-10-09 CN CN202080071169.XA patent/CN114556101B/zh active Active
- 2020-10-09 WO PCT/JP2020/038300 patent/WO2021070934A1/ja not_active Ceased
- 2020-10-09 JP JP2021551720A patent/JP7656829B2/ja active Active
- 2020-10-09 KR KR1020227012018A patent/KR102896955B1/ko active Active
-
2022
- 2022-04-11 US US17/717,764 patent/US12618842B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Van Gool et al. | Analytical techniques for multiplex analysis of protein biomarkers | |
| Wang et al. | Emerging salivary biomarkers by mass spectrometry | |
| KR20180123978A (ko) | 간암 고위험군의 간암 발병 모니터링 또는 진단용 바이오마커 및 그 용도 | |
| Kruse et al. | Development of electrochemiluminescence-based singleplex and multiplex assays for the quantification of α-synuclein and other proteins in cerebrospinal fluid | |
| KR101788414B1 (ko) | 간암 조기 진단용 바이오마커 및 그 용도 | |
| Pedersen et al. | Quantification of multiple elements in dried blood spot samples | |
| Kiernan et al. | Comparative phenotypic analyses of human plasma and urinary retinol binding protein using mass spectrometric immunoassay | |
| JP2023545017A5 (cg-RX-API-DMAC7.html) | ||
| WO2005003767A3 (en) | Elemental analysis of tagged biologically active materials | |
| WO2005027733A2 (en) | Biological markers for diagnosing multiple sclerosis | |
| Krcmova et al. | Determination of neopterin, kynurenine, tryptophan and creatinine in human serum by high throuput HPLC | |
| Ma et al. | Liquid chromatography-tandem mass spectrometry in clinical laboratory protein measurement | |
| WO2021107154A1 (ja) | アルツハイマー型認知症又は軽度認知障害の診断を補助する方法、バイオマーカー、試薬キット及び装置 | |
| US20150203892A1 (en) | Method for determining breast cancer | |
| Roy et al. | Differential expression profiling of serum proteins and metabolites for biomarker discovery | |
| Wijeyesekera et al. | Quantitative UPLC-MS/MS analysis of the gut microbial co-metabolites phenylacetylglutamine, 4-cresyl sulphate and hippurate in human urine: INTERMAP Study | |
| Jahanban-Esfahlan et al. | Optical sensing of albumin in human serum and urine—A historical review of the transition from classical dye-binding assays to advanced technologies | |
| Herwig et al. | Sensitive detection of C-reactive protein in serum by immunoprecipitation–microchip capillary gel electrophoresis | |
| Sauer et al. | Critical role of the sample matrix in a point-of-care protein chip for sepsis | |
| Georgiadis et al. | Development and validation of a direct sandwich chemiluminescence immunoassay for measuring DNA adducts of benzo [a] pyrene and other polycyclic aromatic hydrocarbons | |
| JP2024537879A (ja) | 癌診断用バイオマーカー及びその用途 | |
| JP2023548110A5 (cg-RX-API-DMAC7.html) | ||
| Sirén et al. | Direct monitoring of glycohemoglobin A1c in the blood samples of diabetic patients by capillary electrophoresis: Comparison with an immunoassay method | |
| Balog et al. | Novel automated biomarker discovery work flow for urinary peptidomics | |
| KR101552011B1 (ko) | 리소포스파티딜콜린 및 호모시스테인산을 포함하는 난소암 진단용 조성물 및 이를 사용하여 난소암을 진단하는 방법 |